Harnessing Genomics to drive a step change in personalized medicine A Cancer Genomics Project Manager perspective Cancer Genomics is an area of life science focusing on cancer-associated genomics, epigenomics and transcriptomic alterations, enabling gene-guided diagnosis, prognosis, and identifying eligibility for increased surveillance or personalized therapies, in patients with inherited or acquired cancers. Genomics mainstreaming in the NHS The National Genomic Medicine Service (GMS) has evolved from the world-renowned 100,000 Genomes Project, and is the organization responsible for the detection of cancer-relevant genes. The GMS is divided in to 7 regional Genomic Laboratory Hubs (GLHs). Each GLH delivers Genomic testing that has clear and proven clinical benefit. Providing equitable access to Genomic analysis with an option for Genomic data to be accessed by approved researchers, expanding the genetic diversity of the clinical database, and increasing the discovery of drug-gene